Virtu Financial’s Indaptus Therapeutics INDP Stock Holding History

Virtu Financial’s Portfolio INDP Stock Details INDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18,997	Closed	-$55K	–	1924
2025 Q3	$55K	Buy	+18,997	New	+$137K	﹤0.01%	1119
2025 Q2	–	Sell	-460	Closed	-$7K	–	1734
2025 Q1	$7K	Buy	+460	New	+$10.6K	﹤0.01%	1216
2024 Q2	–	Sell	-508	Closed	-$32K	–	1575
2024 Q1	$32K	Buy	+508	New	+$27K	﹤0.01%	1091
2021 Q1	–	Sell	-594	Closed	-$229K	–	1802
2020 Q4	$229K	Buy	+594	New	+$259K	0.02%	779
2019 Q4	$57K	Sell	51 -8	-14%	-$11K	0.01%	1186
2019 Q3	$96K	Buy	+59	New	+$176K	0.01%	1096
2018 Q1	–	Sell	-8	Closed	-$88K	–	2254
2017 Q4	$88K	Buy	+8	New	+$124K	﹤0.01%	1949

Other funds holding INDP

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Virtu Financial's INDP Position: Q4 2025 in Review

Virtu Financial sold out of Indaptus Therapeutics (INDP) in Q4 2025, closing a stake of 18,997 shares — an estimated $55K sold.

Virtu Financial first reported a position in INDP in Q4 2017 and held it in 7 quarters. The position peaked at $229K in Q4 2020. 4 funds tracked by Wall St. Rank hold INDP as of Q4 2025.

Virtu Financial reported no remaining Indaptus Therapeutics position as of Q4 2025 after selling out during the quarter.
Virtu Financial sold 18,997 Indaptus Therapeutics shares in Q4 2025, an estimated $55K.
Virtu Financial first reported a position in Indaptus Therapeutics in Q4 2017 and held it in 7 quarters.
Virtu Financial's Indaptus Therapeutics position peaked at $229K in Q4 2020.
4 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.